These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14604617)

  • 1. Optimisation versus certainty: understanding the issue of heterogeneity in economic evaluation.
    Stevens W; Normand C
    Soc Sci Med; 2004 Jan; 58(2):315-20. PubMed ID: 14604617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunity costs and uncertainty in the economic evaluation of health care interventions.
    Sendi P; Gafni A; Birch S
    Health Econ; 2002 Jan; 11(1):23-31. PubMed ID: 11788979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Building uncertainty into cost-effectiveness rankings: portfolio risk-return tradeoffs and implications for decision rules.
    O'Brien BJ; Sculpher MJ
    Med Care; 2000 May; 38(5):460-8. PubMed ID: 10800973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of patient preferences for comorbidities in cost-effectiveness analyses.
    Harris RA; Nease RF
    J Health Econ; 1997 Feb; 16(1):113-9. PubMed ID: 10167342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness league tables: think of the fans.
    Drummond M; Mason J; Torrance G
    Health Policy; 1995 Mar; 31(3):231-8. PubMed ID: 10142619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of cost-effectiveness analysis to multiple products: a practical guide.
    Bala MV; Zarkin GA
    Am J Manag Care; 2002 Mar; 8(3):211-8. PubMed ID: 11915971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discounting in health care decision-making: time for a change?
    Sheldon TA
    J Public Health Med; 1992 Sep; 14(3):250-6. PubMed ID: 1419202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing a portfolio of health care programs in the presence of uncertainty and constrained resources.
    Sendi P; Al MJ; Gafni A; Birch S
    Soc Sci Med; 2003 Dec; 57(11):2207-15. PubMed ID: 14512250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncertainty in cost-effectiveness analysis. Probabilistic uncertainty analysis and stochastic league tables.
    Baltussen RM; Hutubessy RC; Evans DB; Murray CJ
    Int J Technol Assess Health Care; 2002; 18(1):112-9. PubMed ID: 11987434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of economic evaluation in health care: Australian decision makers' perceptions.
    Ross J
    Health Policy; 1995 Feb; 31(2):103-10. PubMed ID: 10141251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the estimation of cost-effectiveness ratios.
    Johannesson M
    Health Policy; 1995 Mar; 31(3):225-9. PubMed ID: 10142618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals.
    Bryan S; Williams I; McIver S
    Health Econ; 2007 Feb; 16(2):179-93. PubMed ID: 16960851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making cost assessments based on RCTs more useful to decision-makers.
    Baltussen R; Ament A; Leidl R
    Health Policy; 1996 Sep; 37(3):163-83. PubMed ID: 10160021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Metrics for Economic Evaluation in the Presence of Heterogeneity: Focusing on Evaluating Policy Alternatives Rather than Treatment Alternatives.
    Kim DD; Basu A
    Med Decis Making; 2017 Nov; 37(8):930-941. PubMed ID: 28441507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental cost-effectiveness ratios (ICERs): the silence of the lambda.
    Gafni A; Birch S
    Soc Sci Med; 2006 May; 62(9):2091-100. PubMed ID: 16325975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DH register of cost-effectiveness studies: content and quality.
    Mason J; Drummond M
    Health Trends; 1995; 27(2):50-6. PubMed ID: 10153159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of programmes aiming at eradicating infectious diseases.
    Gyldmark M; Alban A
    Health Policy; 1998 Jul; 45(1):69-79. PubMed ID: 10183014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distributional dilemmas in health policy: large benefits for a few or smaller benefits for many?
    Choudhry N; Slaughter P; Sykora K; Naylor CD
    J Health Serv Res Policy; 1997 Oct; 2(4):212-6. PubMed ID: 10182249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' views of explicit rationing: what are the implications for health service decision-making?
    Devlin N; Appleby J; Parkin D
    J Health Serv Res Policy; 2003 Jul; 8(3):183-6. PubMed ID: 12869346
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.